Literature DB >> 16681680

A study of Gleason score interpretation in different groups of UK pathologists; techniques for improving reproducibility.

D F R Griffiths1, J Melia, L J McWilliam, R Y Ball, K Grigor, P Harnden, M Jarmulowicz, R Montironi, R Moseley, M Waller, S Moss, M C Parkinson.   

Abstract

AIMS: To test the effectiveness of a teaching resource (a decision tree with diagnostic criteria based on published literature) in improving the proficiency of Gleason grading of prostatic cancer by general pathologists.
METHODS: A decision tree with diagnostic criteria was developed by a panel of urological pathologists during a reproducibility study. Twenty-four general histopathologists tested this teaching resource. Twenty slides were selected to include a range of Gleason score groups 2-4, 5-6, 7 and 8-10. Interobserver agreement was studied before and after a presentation of the decision tree and criteria. The results were compared with those of the panel of urological pathologists.
RESULTS: Before the teaching session, 83% of readings agreed within +/- 1 of the panel's consensus scores. Interobserver agreement was low (kappa = 0.33) compared with that for the panel (kappa = 0.62). After the presentation, 90% of readings agreed within +/- 1 of the panel's consensus scores and interobserver agreement amongst the pathologists increased to kappa = 0.41. Most improvement in agreement was seen for the Gleason score group 5-6.
CONCLUSIONS: The lower level of agreement among general pathologists highlights the need to improve observer reproducibility. Improvement associated with a single training session is likely to be limited. Additional strategies include external quality assurance and second opinion within cancer networks.

Entities:  

Mesh:

Year:  2006        PMID: 16681680     DOI: 10.1111/j.1365-2559.2006.02394.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  14 in total

1.  Improving the reproducibility of the Gleason scores in small foci of prostate cancer--suggestion of diagnostic criteria for glandular fusion.

Authors:  B Helpap; G Kristiansen; M Beer; J Köllermann; U Oehler; A Pogrebniak; Ch Fellbaum
Journal:  Pathol Oncol Res       Date:  2011-12-17       Impact factor: 3.201

2.  The value of second-opinion pathology diagnoses on prostate biopsies from patients referred for management of prostate cancer.

Authors:  Al B Barqawi; Ruslan Turcanu; Eduard J Gamito; Scott M Lucia; Colin I O'Donnell; E David Crawford; David D La Rosa; Francisco G La Rosa
Journal:  Int J Clin Exp Pathol       Date:  2011-06-12

Review 3.  [Focal therapy for prostate cancer in Germany - 2014 status].

Authors:  A Roosen; R Ganzer; B Hadaschik; J Köllermann; A Blana; T Henkel; A-B Liehr; D Baumunk; S Machtens; G Salomon; L Sentker; U Witsch; K U Köhrmann; M Schostak
Journal:  Urologe A       Date:  2014-07       Impact factor: 0.639

Review 4.  Does true Gleason pattern 3 merit its cancer descriptor?

Authors:  Saiful Miah; Hashim U Ahmed; Alex Freeman; Mark Emberton
Journal:  Nat Rev Urol       Date:  2016-08-17       Impact factor: 14.432

5.  Frequency and determinants of disagreement and error in gleason scores: a population-based study of prostate cancer.

Authors:  Michael Goodman; Kevin C Ward; Adeboye O Osunkoya; Milton W Datta; Daniel Luthringer; Andrew N Young; Katerina Marks; Vaunita Cohen; Jan C Kennedy; Michael J Haber; Mahul B Amin
Journal:  Prostate       Date:  2012-01-06       Impact factor: 4.104

6.  Genome-wide identification and analysis of prognostic features in human cancers.

Authors:  Joan C Smith; Jason M Sheltzer
Journal:  Cell Rep       Date:  2022-03-29       Impact factor: 9.995

7.  Prostate gland biopsies and prostatectomies: an Ontario community hospital experience.

Authors:  Ken J Newell; John F Amrhein; Rashmikant J Desai; Paul F Middlebrook; Todd M Webster; Barry W Sawka; Brian F Rudrick
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

8.  [Active surveillance of localized prostate cancer. Significance of prostate core needle biopsies].

Authors:  J Rüschoff; P Middel; P Albers
Journal:  Pathologe       Date:  2008-09       Impact factor: 1.011

Review 9.  [Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP)].

Authors:  B Helpap; L Bubendorf; G Kristiansen
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

Review 10.  The evolving Gleason grading system.

Authors:  Ni Chen; Qiao Zhou
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.